Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,24492,1000,1.10 [0.95-1.27],0.2150875655980646
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,24402,195,1.45 [1.08-1.96],0.014530747666004
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,26445,193,1.32 [0.97-1.79],0.0733662728131893
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,18675,774,1.47 [1.26-1.72],9.819471938298395e-07
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26376,124,1.30 [0.89-1.91],0.1712559178367076
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,25291,81,0.78 [0.46-1.33],0.3539316420046448
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27839,123,1.30 [0.89-1.90],0.1745822237704912
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27833,83,1.00 [0.61-1.63],0.9863422437114748
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,24659,66,1.32 [0.78-2.25],0.3000427352445189
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27149,119,0.74 [0.47-1.14],0.1739375010479286
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27098,68,0.59 [0.33-1.07],0.0851694858095949
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27919,78,0.58 [0.33-1.01],0.0536446089427707
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27882,102,1.11 [0.72-1.71],0.6508299740784496
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27877,97,1.10 [0.70-1.71],0.6861663550083867
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Mycoses,27532,64,0.89 [0.50-1.58],0.6831270473756792
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",26704,443,1.03 [0.83-1.28],0.7946642294381643
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26392,131,1.08 [0.73-1.60],0.6963451735708062
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26569,308,1.02 [0.79-1.33],0.8561591187881543
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",22853,51,1.25 [0.68-2.27],0.4720874502882416
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",22866,64,nan [nan-nan],
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",23062,260,nan [nan-nan],
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",23070,268,nan [nan-nan],
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",23480,678,1.19 [1.01-1.41],0.0403987001809713
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22852,50,0.78 [0.40-1.53],0.4714389284756604
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,25033,1044,1.16 [1.01-1.34],0.0332510499687575
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",26831,296,1.00 [0.77-1.30],0.9992458148674028
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27575,109,0.90 [0.58-1.40],0.6438196056136978
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",28013,91,1.12 [0.71-1.77],0.6229646420733298
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Rectum,27792,60,1.13 [0.65-1.98],0.6586032766054271
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,28012,69,0.85 [0.48-1.50],0.574120958797961
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Stomach,28060,54,0.86 [0.45-1.63],0.647277155997672
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm,27833,278,1.11 [0.86-1.45],0.4255098881857113
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,28007,111,1.02 [0.67-1.56],0.9190044883642638
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,28008,107,1.55 [1.06-2.26],0.0251758689218933
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27940,71,1.16 [0.69-1.95],0.5668841975351135
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Haemangioma, any site",27942,70,1.10 [0.65-1.87],0.7284376415812915
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Melanocytic naevi,27843,268,0.95 [0.72-1.26],0.7403845955788346
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,28018,120,0.89 [0.58-1.36],0.583585882584819
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Other benign neoplasms of skin,27908,232,1.18 [0.89-1.57],0.2437732598463444
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm of breast,28000,138,0.96 [0.65-1.41],0.8394920911525092
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Leiomyoma of uterus,27481,1012,1.03 [0.89-1.18],0.7228805661261222
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,26628,274,1.27 [0.98-1.65],0.0670078002810075
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,26353,458,1.17 [0.95-1.44],0.1292475913163534
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,26353,458,1.17 [0.95-1.44],0.1292475913163534
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),24785,419,1.47 [1.19-1.80],0.0002443521514967
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27484,98,0.88 [0.55-1.41],0.5869738472110063
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27701,107,0.79 [0.51-1.24],0.3115539291596132
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23269,931,1.30 [1.13-1.50],0.000330309348067
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,25691,915,1.05 [0.90-1.22],0.5421493586884758
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,26179,122,2.84 [2.14-3.78],6.890730891216518e-13
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27030,61,1.65 [1.02-2.66],0.0426421499121214
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26166,109,2.69 [1.98-3.64],1.920540723386964e-10
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,26477,420,1.93 [1.59-2.33],1.6850817084645578e-11
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26468,411,1.94 [1.60-2.35],1.575547963973054e-11
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,25936,199,1.25 [0.92-1.71],0.1577050658329856
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",25939,196,1.24 [0.91-1.70],0.1774975109782698
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,23072,734,1.28 [1.09-1.51],0.0027306323407105
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",22421,83,1.66 [1.09-2.54],0.0194699912202919
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,23019,681,1.22 [1.03-1.45],0.0225063650074776
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,22389,51,1.45 [0.82-2.56],0.2043239600166631
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",22409,71,1.76 [1.13-2.74],0.013184169604127
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Any mental disorder,23652,630,0.88 [0.73-1.05],0.1590572718328643
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",23141,119,1.31 [0.90-1.92],0.1604378605989187
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27812,79,1.63 [1.06-2.49],0.0254343304558575
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27855,47,1.47 [0.84-2.57],0.1811530098709863
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,26585,38,1.80 [0.99-3.30],0.0558410543808408
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",28008,38,1.77 [0.96-3.24],0.0651397140586861
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",23060,38,1.78 [0.97-3.26],0.0640865541458936
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Alcohol dependence,26571,24,2.71 [1.43-5.11],0.0021435517197883
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Smoking dependency,26465,36,0.86 [0.40-1.83],0.693679626362246
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23065,43,0.69 [0.34-1.43],0.3198391915410663
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",23413,391,0.88 [0.70-1.11],0.2784329660230991
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Depression,26014,348,0.82 [0.64-1.06],0.1275324529671474
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Depression or dysthymia,23192,306,0.86 [0.66-1.12],0.2522350971077023
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",23174,152,0.87 [0.60-1.26],0.4559669454024015
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Other anxiety disorders,26102,77,0.87 [0.52-1.47],0.6071243456806555
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Neurological diseases,24178,1664,1.02 [0.91-1.15],0.6741211017981956
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,22106,186,0.89 [0.63-1.26],0.5123504451265299
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27859,154,0.83 [0.57-1.20],0.3207499914021767
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,26688,432,1.02 [0.82-1.26],0.8838153112713562
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Epilepsy,26397,141,1.10 [0.76-1.59],0.616758755703202
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Migraine,26387,131,0.70 [0.46-1.06],0.0909984491675955
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27606,121,0.71 [0.46-1.10],0.1213602460865578
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27345,60,1.14 [0.65-1.99],0.6434340695999456
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other sleep disorders,26354,98,1.38 [0.92-2.09],0.1213353583599107
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Sleep apnoea,27630,69,1.55 [0.98-2.45],0.0625330796801444
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",26649,877,1.05 [0.90-1.22],0.517297558126748
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",25896,124,0.81 [0.53-1.23],0.3230290911894427
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26332,560,1.13 [0.93-1.36],0.2108784940806964
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27793,76,0.71 [0.41-1.23],0.2247863712008702
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Hemiplegia,27774,57,0.85 [0.46-1.56],0.5953559207970225
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other neurological diseases,27562,126,1.10 [0.75-1.63],0.6177368839525021
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27309,433,1.06 [0.86-1.31],0.5941459770654003
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27131,255,1.16 [0.89-1.53],0.2709434945878985
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26949,73,1.09 [0.65-1.83],0.7316793005498041
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,27014,138,1.07 [0.73-1.56],0.7253016472336102
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26982,106,1.00 [0.64-1.55],0.992146615158254
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23846,182,1.07 [0.76-1.50],0.7010992525541212
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,24083,419,1.46 [1.19-1.79],0.0003048066719688
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,26997,185,1.12 [0.80-1.55],0.513026526476424
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27787,34,2.47 [1.43-4.25],0.0011183192903417
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1809,34,1.76 [1.00-3.11],0.0498583971594154
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",26012,34,2.61 [1.52-4.48],0.0005147618353596
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27335,91,1.20 [0.76-1.89],0.4375646271490353
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27296,52,1.23 [0.67-2.24],0.5003384811495157
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27201,97,0.70 [0.43-1.14],0.1545012920923764
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27471,106,0.94 [0.60-1.46],0.7758511506021626
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,27932,132,0.79 [0.52-1.19],0.2554877180350914
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,27243,105,0.84 [0.53-1.33],0.4605755065710879
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,20640,2843,1.39 [1.27-1.53],1.3010878882682764e-11
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27470,75,2.66 [1.84-3.83],1.6625775304104508e-07
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21681,2093,1.26 [1.13-1.40],3.662458903642502e-05
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Hypertension,21703,2115,1.26 [1.13-1.40],3.277145546095667e-05
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19638,50,1.88 [1.11-3.18],0.0181830222613227
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",26346,739,1.25 [1.06-1.47],0.0067493678300012
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Angina pectoris,26120,513,1.14 [0.94-1.39],0.1912785421994398
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27380,152,1.10 [0.77-1.56],0.6069544238695452
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27459,231,1.05 [0.78-1.41],0.7386303719044787
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27989,28,1.49 [0.72-3.10],0.2827979754211981
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",25704,97,1.04 [0.66-1.64],0.8681785279531677
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26081,486,1.30 [1.07-1.58],0.0075603059561192
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27254,100,1.56 [1.05-2.31],0.0277759525598952
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27356,221,1.24 [0.93-1.65],0.1399213746156132
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27251,97,3.04 [2.25-4.11],4.494429886094525e-13
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27251,97,3.04 [2.25-4.11],4.494429886094525e-13
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19683,95,2.98 [2.19-4.07],5.363433062304322e-12
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,24376,40,2.27 [1.33-3.88],0.0027978006558681
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Conduction disorders,24416,80,1.53 [0.97-2.41],0.0676769574205961
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16833,105,1.98 [1.38-2.85],0.0002378792637468
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,17010,282,3.24 [2.64-3.98],2.9612529996902176e-29
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other arrhythmias,24386,50,2.09 [1.28-3.42],0.0033039706796781
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,24393,57,2.67 [1.77-4.05],3.406896959149187e-06
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27200,102,2.42 [1.76-3.34],5.652874568852901e-08
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27258,129,1.36 [0.95-1.96],0.0936819017544042
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27300,97,1.64 [1.11-2.42],0.012306181798616
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27370,85,1.84 [1.24-2.73],0.0026463066096498
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27055,72,0.65 [0.37-1.16],0.1447137721253279
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27099,116,1.29 [0.87-1.90],0.2052867942879271
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),26408,135,1.08 [0.73-1.58],0.7062637700071922
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26381,108,1.18 [0.78-1.78],0.4331231623837455
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27844,105,1.12 [0.73-1.70],0.6045388126001416
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Varicose veins,26891,618,0.92 [0.76-1.11],0.3846494340155848
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Hypotension,26898,95,1.53 [1.01-2.32],0.0448425543193671
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22793,2136,1.09 [0.99-1.21],0.0892611228123538
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27842,130,0.85 [0.57-1.27],0.4250983203221489
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,26381,200,1.40 [1.05-1.88],0.0228233995754232
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",26362,181,1.45 [1.07-1.97],0.0154474951743689
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27136,233,1.12 [0.84-1.49],0.4403903593434068
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27128,225,1.11 [0.83-1.48],0.4938658170739651
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27275,571,0.76 [0.62-0.93],0.0070680836841668
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Chronic sinusitis,26818,114,0.83 [0.54-1.29],0.4120901711426341
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Nasal polyp,26787,83,1.13 [0.70-1.82],0.618966559299688
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",27064,360,0.75 [0.58-0.96],0.0214213243360194
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Deviated nasal septum,26846,142,0.85 [0.58-1.26],0.427757925272631
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13517,65,0.54 [0.29-1.02],0.0583226882313034
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,25041,1186,1.15 [1.01-1.31],0.0404328705087342
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Early onset COPD,26972,161,1.15 [0.82-1.62],0.4134584362974599
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",26992,181,1.21 [0.88-1.66],0.2420087276768961
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",26992,181,1.21 [0.88-1.66],0.2420087276768961
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",25962,1020,1.15 [1.00-1.32],0.0482278962789898
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Asthma,20839,1020,1.19 [1.03-1.37],0.0164230327660362
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",20645,1020,1.20 [1.04-1.38],0.013401249002685
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",20824,1005,1.19 [1.03-1.38],0.0166639467130056
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27726,83,1.22 [0.76-1.95],0.4083064229820546
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Interstitial lung disease,26230,62,1.07 [0.60-1.89],0.8236949269899986
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",27802,62,1.07 [0.61-1.89],0.8024779171127252
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26223,55,1.13 [0.62-2.06],0.6788940635261125
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pleural effusion,26176,89,1.71 [1.14-2.56],0.0091737437840513
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other diseases of pleura,26283,196,1.94 [1.49-2.51],7.077463777143048e-07
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,26868,94,2.04 [1.42-2.93],0.0001075313312563
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19410,6113,0.90 [0.83-0.96],0.0030348791660497
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27477,482,0.99 [0.80-1.21],0.8959627119197969
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,28014,108,1.12 [0.73-1.70],0.6059170484320842
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Impacted teeth,28019,97,1.15 [0.74-1.79],0.525642844707761
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Dental caries,27102,107,1.12 [0.73-1.71],0.6013814396320005
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,27116,121,1.27 [0.87-1.87],0.2222016351423864
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,28004,119,1.01 [0.67-1.52],0.9476847095630868
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,27113,118,0.85 [0.56-1.31],0.4662027225708833
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26807,80,0.89 [0.53-1.50],0.672288984931612
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27918,50,0.79 [0.40-1.54],0.4898060401358769
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,21198,224,0.88 [0.64-1.20],0.4217777821960895
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",23331,2357,0.82 [0.74-0.91],0.0001591576172529
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Oesophagitis,21266,292,0.74 [0.56-0.98],0.0384588995039633
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,21730,756,0.66 [0.55-0.79],8.386473675110576e-06
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,21053,79,1.21 [0.75-1.97],0.4298050581179298
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,21110,136,1.03 [0.70-1.52],0.8898831870097547
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,21015,41,0.56 [0.26-1.24],0.1550529321002758
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastric ulcer,21122,148,0.75 [0.51-1.12],0.1626004757504821
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Duodenal ulcer,21051,77,1.24 [0.76-2.02],0.3893411285956785
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27968,55,1.14 [0.64-2.04],0.6613122527375743
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Chronic gastritis,21111,137,1.04 [0.71-1.53],0.8262740189689083
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),21836,862,0.88 [0.75-1.03],0.1178369171499948
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of appendix,27888,148,0.82 [0.56-1.21],0.3203454921145454
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Functional dyspepsia,21560,586,0.91 [0.75-1.11],0.3672310874790132
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,21155,181,0.83 [0.58-1.18],0.291091890108265
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27927,145,1.17 [0.82-1.67],0.3902948495451444
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute appendicitis,27859,119,0.97 [0.64-1.46],0.8688075872057546
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Hernia,25116,1223,0.82 [0.72-0.95],0.006079931033534
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Inguinal hernia,23962,69,1.04 [0.60-1.78],0.893095672942657
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Umbilical hernia,23967,74,1.15 [0.69-1.89],0.596279114344523
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Ventral hernia,24003,110,1.65 [1.15-2.37],0.0067845816037095
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,24871,978,0.71 [0.60-0.83],1.6173410284931764e-05
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26949,924,1.13 [0.97-1.31],0.1080007211525305
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of intestines,22214,2232,1.03 [0.93-1.14],0.5232440549853228
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27702,64,1.72 [1.06-2.78],0.0275298965498053
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",27985,93,1.87 [1.28-2.74],0.0012775819580658
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Crohn disease,26118,93,1.89 [1.29-2.77],0.0011876890881856
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26093,68,2.03 [1.32-3.14],0.0013390405857577
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",27906,134,1.47 [1.04-2.07],0.0303874773603379
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Ulcerative colitis,26159,134,1.48 [1.04-2.09],0.0277313895833783
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26145,120,1.61 [1.13-2.30],0.0089802239776726
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26807,782,1.07 [0.91-1.25],0.4281993237848381
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26796,771,1.05 [0.89-1.24],0.537686727187916
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,20089,107,1.23 [0.81-1.86],0.3348575129751591
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Intestinal stricture,27572,107,1.23 [0.82-1.86],0.3162659181844617
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",20048,66,1.46 [0.89-2.40],0.1347295120889769
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20663,681,0.95 [0.79-1.14],0.5835780999767229
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,20232,250,0.92 [0.69-1.24],0.5879964481640325
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,20382,400,1.05 [0.84-1.32],0.6764205140785704
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Constipation,26310,356,1.06 [0.84-1.35],0.6217326146640396
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27530,126,0.90 [0.60-1.35],0.5963254768451052
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,20109,127,0.98 [0.65-1.46],0.9022960012769776
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,20030,48,1.11 [0.59-2.07],0.7490024373431607
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,20889,907,1.13 [0.97-1.31],0.1073849379889151
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of intestine,20220,238,1.38 [1.05-1.81],0.0189069184608047
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27512,108,0.97 [0.63-1.49],0.8748855330299127
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of liver,27250,107,3.34 [2.53-4.41],1.5924597981797506e-17
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of liver,27197,54,2.91 [1.95-4.35],1.6620517600836077e-07
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",26449,898,0.95 [0.82-1.11],0.5483071834265325
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Cholelithiasis,26301,750,0.85 [0.72-1.01],0.0716158659119327
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Cholecystitis,25687,136,1.30 [0.91-1.86],0.1467616753944914
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,25622,71,1.31 [0.80-2.15],0.2882466868859545
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute pancreatitis,25614,63,1.20 [0.70-2.06],0.4981469399391078
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),27894,63,1.22 [0.72-2.08],0.4661666351583673
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,26637,312,0.76 [0.58-0.99],0.0432975304360864
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26431,106,0.51 [0.32-0.83],0.0070473615488327
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Coeliac disease,26415,90,0.46 [0.27-0.78],0.0041512487441868
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26365,40,1.45 [0.77-2.72],0.2470992518903618
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,26496,171,0.78 [0.54-1.12],0.1704784397288093
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,GI-bleeding,26486,161,0.77 [0.53-1.12],0.1749776748906077
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,24827,1648,1.06 [0.94-1.18],0.3489717096679917
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27582,117,1.16 [0.77-1.73],0.4792956526794028
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27586,464,0.86 [0.69-1.07],0.1677111786071146
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,26444,710,1.03 [0.86-1.22],0.7762197602860115
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27212,329,1.24 [0.98-1.56],0.0712700307772546
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26954,71,0.95 [0.56-1.63],0.8610116410518567
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27093,210,1.39 [1.05-1.83],0.0210940941221673
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27759,92,1.21 [0.78-1.89],0.3952685300457583
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27731,64,1.39 [0.84-2.31],0.2037397022652638
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27718,51,1.91 [1.15-3.16],0.012026781417022
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27776,55,1.06 [0.58-1.94],0.847887605888811
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27773,52,1.05 [0.56-1.96],0.8773887855266712
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,27180,58,0.42 [0.22-0.80],0.0089727171346608
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27485,363,0.99 [0.78-1.26],0.9369962412156004
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,25840,106,1.07 [0.69-1.65],0.7760312229103342
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,25894,160,1.24 [0.88-1.74],0.2164078419310852
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,25850,116,1.22 [0.81-1.82],0.3407078862130798
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",25995,261,0.91 [0.68-1.21],0.5024107480070616
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,25971,237,1.00 [0.74-1.34],0.9769854761645352
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19751,4487,0.88 [0.81-0.95],0.0020153968540364
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21523,2585,0.94 [0.85-1.04],0.2229085070663351
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,25177,1359,0.96 [0.85-1.10],0.5794798988811027
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,19154,216,1.18 [0.88-1.59],0.2677854850806972
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19465,527,0.94 [0.77-1.15],0.5382402017438149
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27458,207,1.15 [0.85-1.56],0.3612879212352862
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27475,189,1.24 [0.91-1.69],0.1801870662527338
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20195,1257,0.88 [0.76-1.01],0.0738020289909969
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",22955,1257,0.87 [0.76-1.00],0.0527116141576505
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18950,12,0.69 [0.16-2.91],0.6141092139078485
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27851,12,0.70 [0.17-2.80],0.6119170861740664
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,19221,283,0.82 [0.62-1.09],0.1787225500208924
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,19028,90,1.00 [0.62-1.61],0.9929884492811314
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,19252,314,0.89 [0.68-1.16],0.3905265602349276
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27850,158,1.03 [0.72-1.48],0.8588659785981027
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19433,495,0.89 [0.72-1.11],0.2963180452300084
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19434,496,0.94 [0.76-1.16],0.5688227995044074
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,20382,1444,1.01 [0.89-1.14],0.9025886458404222
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),19047,109,1.04 [0.67-1.60],0.8592428850053635
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),19367,429,0.83 [0.66-1.05],0.115295851695034
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,19022,84,1.00 [0.61-1.64],0.9926348321762418
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),19045,107,0.60 [0.37-0.98],0.0394540141300699
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19316,378,1.19 [0.96-1.49],0.1187502270351109
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,19260,322,1.13 [0.89-1.45],0.3168359375408563
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,20902,305,0.96 [0.74-1.25],0.7645462411349697
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27212,223,0.60 [0.43-0.83],0.0022848501080638
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27083,94,0.85 [0.52-1.38],0.5075645704320804
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,24001,85,1.07 [0.66-1.73],0.792469235544213
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,24229,313,0.71 [0.54-0.94],0.015336123996363
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,24968,1052,0.74 [0.64-0.87],0.0001244977922672
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,24137,221,0.57 [0.40-0.79],0.0009866516980736
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,23995,79,1.01 [0.61-1.67],0.9786666864002728
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",24753,837,0.75 [0.63-0.89],0.0007089464640955
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,23969,53,0.87 [0.46-1.63],0.6636675264810357
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,24164,248,0.74 [0.54-1.00],0.0529474752847594
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,24021,105,0.88 [0.56-1.39],0.5970435453113767
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,24010,94,0.82 [0.50-1.32],0.4093957176724772
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,24082,166,0.92 [0.64-1.31],0.6359909457182663
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,23993,77,0.85 [0.50-1.45],0.5477295786996834
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,24278,362,0.58 [0.45-0.75],3.881779778758625e-05
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,24209,391,0.85 [0.67-1.08],0.1762547847046851
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,23894,76,0.73 [0.42-1.27],0.2658708790371269
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,23930,112,1.05 [0.69-1.60],0.8255142222829076
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23963,145,0.72 [0.48-1.07],0.1058621611214743
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",23857,39,1.20 [0.61-2.37],0.6004774253780427
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,23877,59,1.09 [0.61-1.95],0.7635183592305016
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],23861,43,1.18 [0.60-2.30],0.6327007775777931
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,24101,283,1.00 [0.76-1.31],0.9996010900907788
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,23879,61,0.85 [0.47-1.54],0.594184949522973
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,23888,70,0.73 [0.41-1.29],0.2731398826951419
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,23960,142,0.93 [0.63-1.37],0.7081179480794741
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,23901,83,0.50 [0.29-0.87],0.0139904083237802
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",24369,551,1.08 [0.89-1.30],0.4414955630006243
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,24012,194,1.32 [0.98-1.77],0.0658853683276711
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,24115,297,1.07 [0.82-1.38],0.6269078632218614
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,25255,240,0.82 [0.60-1.11],0.1966293350481586
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,25508,493,0.87 [0.70-1.07],0.1903367313032581
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,25056,41,0.89 [0.43-1.84],0.757929520111823
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,25082,67,0.76 [0.42-1.36],0.3522223402017325
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,25133,118,0.72 [0.46-1.13],0.1514374945407537
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,22888,6224,0.95 [0.89-1.02],0.1709765579218268
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,25544,204,1.12 [0.82-1.53],0.4730408737823789
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,25385,45,0.94 [0.47-1.87],0.8553628778868112
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,25720,36,1.21 [0.59-2.48],0.5992273082749116
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,25733,49,1.88 [1.12-3.17],0.0177885877086786
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,25725,41,1.10 [0.55-2.21],0.7894611877508262
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27804,134,1.07 [0.73-1.56],0.734374311378461
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27682,67,2.48 [1.68-3.67],4.830009252269231e-06
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27771,101,1.03 [0.66-1.61],0.8820152849697032
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27708,38,1.04 [0.50-2.14],0.9250555795455108
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,25784,1275,0.93 [0.81-1.06],0.2759307394223774
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Cystitis,24647,138,1.21 [0.83-1.76],0.3143159477652347
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,24598,89,1.01 [0.62-1.64],0.9803542324832152
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,24680,171,0.88 [0.61-1.26],0.4866046329962877
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,24598,89,1.04 [0.64-1.69],0.8758002397981174
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,25514,1005,0.93 [0.80-1.08],0.336971261051137
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27736,485,0.98 [0.80-1.21],0.858673923176545
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27401,150,0.91 [0.62-1.33],0.6235441553435974
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,27422,171,0.96 [0.68-1.36],0.8121053736244891
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27364,113,1.04 [0.69-1.59],0.8411200305898944
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27673,565,0.79 [0.65-0.97],0.0223722500850873
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,27242,134,0.78 [0.52-1.18],0.2349233231730429
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,27360,252,0.84 [0.63-1.13],0.2492200436918201
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,25573,4660,0.93 [0.86-1.00],0.0395302326264173
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Endometriosis,21280,367,0.81 [0.63-1.03],0.0884497999052524
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,21011,98,0.75 [0.47-1.20],0.2276869278040886
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),21083,170,0.60 [0.41-0.87],0.0066600268327037
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21719,806,0.66 [0.56-0.79],5.216863968963422e-06
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,21330,417,0.79 [0.62-0.99],0.0422077511886206
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21887,974,1.01 [0.87-1.18],0.8534615523415061
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,21234,321,0.99 [0.77-1.27],0.9228709397119766
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21359,446,1.06 [0.86-1.31],0.5797377374845253
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,21014,101,0.81 [0.51-1.29],0.3752884964143835
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,21104,191,0.76 [0.54-1.07],0.1191750703412865
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",28013,270,0.91 [0.69-1.20],0.5058331363764439
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,28025,256,0.92 [0.69-1.23],0.5895662695695718
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,28051,142,1.06 [0.73-1.54],0.7485440719189241
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",28040,156,1.02 [0.71-1.46],0.9055106464349372
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,21061,148,0.98 [0.67-1.42],0.8955109026427713
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,21028,115,1.07 [0.71-1.63],0.7365597995088207
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,21058,145,1.24 [0.87-1.77],0.2293556951870381
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Irregular menses,27942,474,1.01 [0.82-1.25],0.899511981323136
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",22277,1364,0.99 [0.87-1.12],0.8551892413048279
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21803,890,0.97 [0.83-1.14],0.7387875285024397
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",28030,197,1.07 [0.78-1.47],0.6565959838879751
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,21387,474,0.88 [0.71-1.09],0.2451238717518437
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,21247,334,0.88 [0.68-1.13],0.3152087244395216
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21821,908,1.21 [1.04-1.40],0.0131189536469251
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Female infertility,21028,115,1.10 [0.73-1.67],0.6440038727758073
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",21021,108,1.11 [0.73-1.70],0.6306641750894577
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,28047,888,0.88 [0.75-1.05],0.1505638907651458
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,28050,1214,0.92 [0.79-1.06],0.245421528985682
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,28048,487,0.92 [0.75-1.14],0.450862138151083
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,27699,138,0.84 [0.57-1.24],0.376567644179109
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,27756,195,1.00 [0.73-1.39],0.9858870841594072
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,27731,170,0.90 [0.64-1.28],0.5637112114305811
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",28066,168,1.06 [0.75-1.50],0.7597653224517043
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,28068,165,1.04 [0.73-1.48],0.8301932591479202
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,28066,423,0.98 [0.78-1.23],0.8384457717906479
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,27770,127,0.99 [0.66-1.47],0.9566124156671828
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,27876,233,0.96 [0.71-1.30],0.7908461168754121
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,27308,149,0.68 [0.46-1.00],0.0485617450149414
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,27362,203,1.05 [0.77-1.45],0.7457363390456424
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,27412,253,0.92 [0.69-1.24],0.5955873431385542
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,27307,148,0.74 [0.50-1.10],0.1334538639192438
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,27299,140,0.61 [0.41-0.92],0.0174991828520297
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,27312,153,0.91 [0.63-1.32],0.627920177129542
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,27071,235,0.83 [0.61-1.13],0.2312035244895071
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],27280,444,0.90 [0.72-1.13],0.3616984334115111
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,27515,679,0.94 [0.78-1.14],0.5315748157207469
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",28069,173,1.50 [1.09-2.07],0.0126041365562818
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,26594,132,1.57 [1.09-2.24],0.0140003386023903
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",26939,103,1.17 [0.76-1.80],0.4825093024589046
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,28078,346,0.88 [0.69-1.13],0.331197465826361
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,27996,264,0.86 [0.65-1.14],0.2956273668489636
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",28064,257,0.78 [0.58-1.04],0.0897890878377229
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",28054,247,0.75 [0.56-1.02],0.0663869876887099
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27768,45,1.73 [0.99-3.02],0.0553846649848294
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,25105,654,1.18 [0.99-1.40],0.0594043989775076
